Testosterone Esters
Cypionate vs Enanthate vs Propionate, How the Ester Sets the Half-Life
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Cypionate & Enanthate FDA Approved; Propionate limited US availability
- WADA
- Prohibited (S1 Anabolic Agent)
Reference only. Not medical advice.
What can go wrong
Injectable peaks drive erythrocytosis more than transdermal routes; biweekly dosing causes symptomatic peak-trough fluctuation; oil-based intramuscular injections carry rare risk of cough/POME-type reactions and injection-site issues. Propionate's frequent injections increase site irritation.
This is something to take to a clinician. The Atlas can tell you what is known about testosterone esters in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Injectable testosterone is the hormone bonded to a fatty-acid ester that controls how slowly it releases from the oil depot. The molecule that reaches receptors is identical testosterone; the ester only sets the pharmacokinetics. Cypionate (8-carbon) and enanthate (7-carbon) have long half-lives suited to weekly or biweekly dosing and are the US TRT mainstays; propionate (3-carbon) has a short half-life requiring every-other-day injection and is little used clinically. Cypionate (Depo-Testosterone, Pfizer) is the most common US formulation.
Same hormone, different chemical tail, and the tail decides how often you inject.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
After injection into an oil depot, esterases cleave the fatty-acid ester, releasing free testosterone into circulation. A longer carbon chain (cypionate > enanthate > propionate) increases lipophilicity, slows depot release, and lengthens half-life. Once cleaved, the active hormone is the same regardless of ester, the ester governs timing, not potency.
Peak-trough is a frequency problem, not a drug problem
Because the active molecule is identical across esters, complaints of 'cypionate didn't work but enanthate did' usually reflect dosing frequency and depot kinetics, not a difference in the hormone. Biweekly long-ester injection produces a high peak early and a low trough before the next dose, with mood and libido tracking the curve; the modern fix is more frequent, smaller injections (weekly or twice-weekly) or subcutaneous administration to flatten the curve. The early post-injection peak is also where supraphysiological levels and hematocrit spikes arise in non-deficient men.
Safety in detail
Injectable testosterone esters require evaluation, dose selection, and monitoring by a qualified physician. Self-administration and supraphysiological dosing carry documented health risks including erythrocytosis and HPG suppression.
Replacement is not the same as a cycle
TRT replacement is 50-150 mg/week; the same esters at 300-1000+ mg/week constitute supraphysiological/anabolic use, producing the highest peaks, the greatest hematocrit elevation, and HPG suppression, the same molecule and ester, redefined by dose and intent.
What it does to fertility
All testosterone esters suppress LH/FSH and spermatogenesis; longer esters sustain suppression between injections. None preserve fertility, unlike nasal testosterone or enclomiphene.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Hematocrit
- Total testosterone measured at trough for long esters
- PSA per guideline
- Symptom tracking across the dosing interval
- Blood pressure
What people get wrong
Often saidOne ester is more powerful than another
ActuallyThe active hormone is identical; esters change only release timing and dosing frequency, not potency.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
Cypionate and enanthate are clinically near-interchangeable; cypionate's slightly longer half-life is the basis for its US dominance, while enanthate is more common internationally. Both allow weekly (or biweekly) dosing but produce peak-trough swings, more pronounced with biweekly intervals, that can make mood and libido fluctuate. Propionate's short half-life smooths peaks but demands every-other-day injection, limiting practicality for replacement.
| Ester | Half-life | Typical TRT frequency | Status |
|---|---|---|---|
| Cypionate | ~8 days | Weekly / biweekly | FDA approved, most common US |
| Enanthate | ~4-5 days | Weekly / biweekly | FDA approved, common globally |
| Propionate | ~20 hours | Every other day | Limited US availability, rarely used for TRT |
At a glance
- Cypionate half-life
- ~8 days
- Enanthate half-life
- ~4-5 days
- Propionate half-life
- ~0.8 days
- Most common US
- Cypionate
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Testosterone Esters. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Pharmacokinetic comparisons of testosterone estersVarious
Half-life lengthens with ester carbon-chain length; active hormone identical across esters
Subcutaneous vs intramuscular testosterone studies2018-2021
Subcutaneous dosing shows equivalent efficacy with flatter levels and better tolerability